The genomic medicine alliance: A global effort to facilitate the introduction of genomics into healthcare in developing nations

David N. Cooper, Christina Mitropoulou, Angela Brand, Vita Dolzan, Paolo Fortina, Federico Innocenti, Ming T.M. Lee, Milan Macek, Konstantinos Mitropoulos, Fahd Al-Mulla, Barbara Prainsack, Ron H. van Schaik, Alessio Squassina, Domenica Taruscio, Effy Vayena, Athanassios Vozikis, Marc S. Williams, Bauke Ylstra, George P. Patrinos

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

The primary goal of genomic medicine is to make use of an individual's genomic information to support the clinical decision-making process. At present, several international organizations and research consortia exist, which aim to support the translation of genomic research into clinical practice so that genomic medicine can ultimately be used to benefit the global community. The Genomic Medicine Alliance (http://www.genomicmedicinealliance.org/) is a global academic research network that seeks to establish and strengthen collaborative ties between different genomic medicine stakeholders. Its focus lies firmly with the translation of scientific research findings into clinical practice. To this end, it brings together experts from various disciplines including genome informatics, pharmacogenomics, and public health genomics, as well as experts on ethical, legal, and social issues in the sphere of genomics/health economics. These multidisciplinary activities are supervised by a 15-member International Scientific Advisory Committee. Its official journal, Public Health Genomics, offers members a highly respected publication forum for reviews, original research findings, and policy in this field. In the short-to-medium term, the Genomic Medicine Alliance aims to promote research collaborations between developed and developing countries and to organize educational activities in the field of genomic medicine. In the longer term, it aspires to become a focal point for global collaboration in the field of genomic medicine while helping to pave the way for a smoother transition from genomics research to genomic medicine.

Original languageEnglish
Title of host publicationGenomic Medicine in Emerging Economies
Subtitle of host publicationGenomics for Every Nation
PublisherElsevier
Pages173-188
Number of pages16
ISBN (Print)9780128115312
DOIs
Publication statusPublished - 01-01-2018

Fingerprint

Genomics
Developing Countries
Medicine
Delivery of Health Care
Research
Public health
Public Health Informatics
Pharmacogenetics
Advisory Committees
Developed Countries
Developing countries
Publications
Public Health
Genes
Decision making
Economics
Health
Organizations
Genome
Education

All Science Journal Classification (ASJC) codes

  • Biochemistry, Genetics and Molecular Biology(all)

Cite this

Cooper, D. N., Mitropoulou, C., Brand, A., Dolzan, V., Fortina, P., Innocenti, F., ... Patrinos, G. P. (2018). The genomic medicine alliance: A global effort to facilitate the introduction of genomics into healthcare in developing nations. In Genomic Medicine in Emerging Economies: Genomics for Every Nation (pp. 173-188). Elsevier. https://doi.org/10.1016/B978-0-12-811531-2.00010-2
Cooper, David N. ; Mitropoulou, Christina ; Brand, Angela ; Dolzan, Vita ; Fortina, Paolo ; Innocenti, Federico ; Lee, Ming T.M. ; Macek, Milan ; Mitropoulos, Konstantinos ; Al-Mulla, Fahd ; Prainsack, Barbara ; van Schaik, Ron H. ; Squassina, Alessio ; Taruscio, Domenica ; Vayena, Effy ; Vozikis, Athanassios ; Williams, Marc S. ; Ylstra, Bauke ; Patrinos, George P. / The genomic medicine alliance : A global effort to facilitate the introduction of genomics into healthcare in developing nations. Genomic Medicine in Emerging Economies: Genomics for Every Nation. Elsevier, 2018. pp. 173-188
@inbook{521b8b493f44419dbd8dda01a15406c4,
title = "The genomic medicine alliance: A global effort to facilitate the introduction of genomics into healthcare in developing nations",
abstract = "The primary goal of genomic medicine is to make use of an individual's genomic information to support the clinical decision-making process. At present, several international organizations and research consortia exist, which aim to support the translation of genomic research into clinical practice so that genomic medicine can ultimately be used to benefit the global community. The Genomic Medicine Alliance (http://www.genomicmedicinealliance.org/) is a global academic research network that seeks to establish and strengthen collaborative ties between different genomic medicine stakeholders. Its focus lies firmly with the translation of scientific research findings into clinical practice. To this end, it brings together experts from various disciplines including genome informatics, pharmacogenomics, and public health genomics, as well as experts on ethical, legal, and social issues in the sphere of genomics/health economics. These multidisciplinary activities are supervised by a 15-member International Scientific Advisory Committee. Its official journal, Public Health Genomics, offers members a highly respected publication forum for reviews, original research findings, and policy in this field. In the short-to-medium term, the Genomic Medicine Alliance aims to promote research collaborations between developed and developing countries and to organize educational activities in the field of genomic medicine. In the longer term, it aspires to become a focal point for global collaboration in the field of genomic medicine while helping to pave the way for a smoother transition from genomics research to genomic medicine.",
author = "Cooper, {David N.} and Christina Mitropoulou and Angela Brand and Vita Dolzan and Paolo Fortina and Federico Innocenti and Lee, {Ming T.M.} and Milan Macek and Konstantinos Mitropoulos and Fahd Al-Mulla and Barbara Prainsack and {van Schaik}, {Ron H.} and Alessio Squassina and Domenica Taruscio and Effy Vayena and Athanassios Vozikis and Williams, {Marc S.} and Bauke Ylstra and Patrinos, {George P.}",
year = "2018",
month = "1",
day = "1",
doi = "10.1016/B978-0-12-811531-2.00010-2",
language = "English",
isbn = "9780128115312",
pages = "173--188",
booktitle = "Genomic Medicine in Emerging Economies",
publisher = "Elsevier",
address = "Netherlands",

}

Cooper, DN, Mitropoulou, C, Brand, A, Dolzan, V, Fortina, P, Innocenti, F, Lee, MTM, Macek, M, Mitropoulos, K, Al-Mulla, F, Prainsack, B, van Schaik, RH, Squassina, A, Taruscio, D, Vayena, E, Vozikis, A, Williams, MS, Ylstra, B & Patrinos, GP 2018, The genomic medicine alliance: A global effort to facilitate the introduction of genomics into healthcare in developing nations. in Genomic Medicine in Emerging Economies: Genomics for Every Nation. Elsevier, pp. 173-188. https://doi.org/10.1016/B978-0-12-811531-2.00010-2

The genomic medicine alliance : A global effort to facilitate the introduction of genomics into healthcare in developing nations. / Cooper, David N.; Mitropoulou, Christina; Brand, Angela; Dolzan, Vita; Fortina, Paolo; Innocenti, Federico; Lee, Ming T.M.; Macek, Milan; Mitropoulos, Konstantinos; Al-Mulla, Fahd; Prainsack, Barbara; van Schaik, Ron H.; Squassina, Alessio; Taruscio, Domenica; Vayena, Effy; Vozikis, Athanassios; Williams, Marc S.; Ylstra, Bauke; Patrinos, George P.

Genomic Medicine in Emerging Economies: Genomics for Every Nation. Elsevier, 2018. p. 173-188.

Research output: Chapter in Book/Report/Conference proceedingChapter

TY - CHAP

T1 - The genomic medicine alliance

T2 - A global effort to facilitate the introduction of genomics into healthcare in developing nations

AU - Cooper, David N.

AU - Mitropoulou, Christina

AU - Brand, Angela

AU - Dolzan, Vita

AU - Fortina, Paolo

AU - Innocenti, Federico

AU - Lee, Ming T.M.

AU - Macek, Milan

AU - Mitropoulos, Konstantinos

AU - Al-Mulla, Fahd

AU - Prainsack, Barbara

AU - van Schaik, Ron H.

AU - Squassina, Alessio

AU - Taruscio, Domenica

AU - Vayena, Effy

AU - Vozikis, Athanassios

AU - Williams, Marc S.

AU - Ylstra, Bauke

AU - Patrinos, George P.

PY - 2018/1/1

Y1 - 2018/1/1

N2 - The primary goal of genomic medicine is to make use of an individual's genomic information to support the clinical decision-making process. At present, several international organizations and research consortia exist, which aim to support the translation of genomic research into clinical practice so that genomic medicine can ultimately be used to benefit the global community. The Genomic Medicine Alliance (http://www.genomicmedicinealliance.org/) is a global academic research network that seeks to establish and strengthen collaborative ties between different genomic medicine stakeholders. Its focus lies firmly with the translation of scientific research findings into clinical practice. To this end, it brings together experts from various disciplines including genome informatics, pharmacogenomics, and public health genomics, as well as experts on ethical, legal, and social issues in the sphere of genomics/health economics. These multidisciplinary activities are supervised by a 15-member International Scientific Advisory Committee. Its official journal, Public Health Genomics, offers members a highly respected publication forum for reviews, original research findings, and policy in this field. In the short-to-medium term, the Genomic Medicine Alliance aims to promote research collaborations between developed and developing countries and to organize educational activities in the field of genomic medicine. In the longer term, it aspires to become a focal point for global collaboration in the field of genomic medicine while helping to pave the way for a smoother transition from genomics research to genomic medicine.

AB - The primary goal of genomic medicine is to make use of an individual's genomic information to support the clinical decision-making process. At present, several international organizations and research consortia exist, which aim to support the translation of genomic research into clinical practice so that genomic medicine can ultimately be used to benefit the global community. The Genomic Medicine Alliance (http://www.genomicmedicinealliance.org/) is a global academic research network that seeks to establish and strengthen collaborative ties between different genomic medicine stakeholders. Its focus lies firmly with the translation of scientific research findings into clinical practice. To this end, it brings together experts from various disciplines including genome informatics, pharmacogenomics, and public health genomics, as well as experts on ethical, legal, and social issues in the sphere of genomics/health economics. These multidisciplinary activities are supervised by a 15-member International Scientific Advisory Committee. Its official journal, Public Health Genomics, offers members a highly respected publication forum for reviews, original research findings, and policy in this field. In the short-to-medium term, the Genomic Medicine Alliance aims to promote research collaborations between developed and developing countries and to organize educational activities in the field of genomic medicine. In the longer term, it aspires to become a focal point for global collaboration in the field of genomic medicine while helping to pave the way for a smoother transition from genomics research to genomic medicine.

UR - http://www.scopus.com/inward/record.url?scp=85065881423&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85065881423&partnerID=8YFLogxK

U2 - 10.1016/B978-0-12-811531-2.00010-2

DO - 10.1016/B978-0-12-811531-2.00010-2

M3 - Chapter

AN - SCOPUS:85065881423

SN - 9780128115312

SP - 173

EP - 188

BT - Genomic Medicine in Emerging Economies

PB - Elsevier

ER -

Cooper DN, Mitropoulou C, Brand A, Dolzan V, Fortina P, Innocenti F et al. The genomic medicine alliance: A global effort to facilitate the introduction of genomics into healthcare in developing nations. In Genomic Medicine in Emerging Economies: Genomics for Every Nation. Elsevier. 2018. p. 173-188 https://doi.org/10.1016/B978-0-12-811531-2.00010-2